Kursprognose für Biodexa Pharmaceuticals PLC (BDRX)BDRXBiodexa Pharmaceuticals PLC

Alphio's BDRX stock price prediction model matches the current Biodexa Pharmaceuticals PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.42 (-0.48%). The 1-week path is $0.42 (-0.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Biodexa Pharmaceuticals (BDRX) is not a good buy right now due to a significant decline in stock value, with a year-to-date change of -96.29% and a current price of $0.46, which is far below its historical highs. The RSI is at 41.805, indicating a potential oversold condition, but the overall trend is negative. The company has also reported a forward P/E of 0, suggesting uncertainty in future earnings, and the price-to-sales ratio of 11.46 indicates overvaluation relative to sales. The main risk is the company's financial instability, as evidenced by a negative P/E ratio of -0.089 and a staggering FCF yield of -1943.581, which raises concerns about its ability to generate cash flow.

Biodexa Pharmaceuticals PLC (BDRX) last closed at $0.4199, gaining +8.91%. These facts feed the 1-day and 1-week BDRX price prediction above.